CNTMF - Cansortium Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.5530
+0.0190 (+3.56%)
At close: 2:51PM EST
Stock chart is not supported by your current browser
Previous Close0.5340
Open0.5250
BidN/A x N/A
AskN/A x N/A
Day's Range0.5150 - 0.6400
52 Week Range0.3398 - 2.5000
Volume6,151
Avg. Volume31,453
Market Cap107.003M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Cansortium Attributes Lower Q2 Revenue To 'Unexpected Delays,' Halves 2019 Outlook

    Cansortium achieved positive consolidated EBITDA of $1.8 million versus pro-forma EBITDA of $5.8 million in the second quarter of 2018. Consolidated adjusted EBITDA for the quarter was a loss of $2.6 million, compared to adjusted pro-forma positive EBITDA of $100,000 in the same quarter of the previous year. For the first half of 2019, the company reported consolidated revenue of $11.6 million, up by 37% from pro-forma revenue of $8.5 million in the first half of 2018.

  • Benzinga

    Cansortium Analyst Sees 'Dramatic Expansion' Potential In Canadian Cannabis Market

    Cansortium's focus is on the medical cannabis space in Florida, where it oversees 11 dispensaries and is considered a "large player" in the regulated cannabis market, Burleson said in the Friday initiation note.

  • We're sorry this is all we were able to find about this topic.